Migraine is a Serious Neurological Disease

Migraine is a Serious Neurological Disease

Migraine is more than headache pain. Migraine has multiple symptoms, which may include extreme sensitivity to light and sound, as well as nausea. A migraine attack can last from several hours to several days and severely impair daily function. Migraine can continue over a lifetime.

Learn More

Migraine and Cardiovascular Risks

Migraine and Cardiovascular Risks

Migraine is associated with greater risk for cardiovascular disease. However, legacy treatments for migraine also have unwanted cardiovascular effects, and in rare cases, can cause cardiovascular events.

Learn More

Triptans vs. Ditans—What’s the Difference?

Triptans vs. Ditans—What’s the Difference?

Not all therapies are created the same way. Legacy treatments such as triptans are designed to relieve migraine through vasoconstrictive effects on blood vessels, while ditans are designed to act in the brain to relieve migraine without vasoconstriction.

Learn More

Who Gets Migraine?

Who Gets Migraine?

It’s not just a disease of young women—migraine can strike anyone at any age. Do you know migraine is an important risk factor for coronary artery disease events? And CV risks affect migraine treatments?

 

For answers to these and other important questions, read Facts Addressing Migraine Misperceptions,  a 2016 white paper by IMS Health.

Learn More

Lasmiditan— an innovative new drug in the ditan class

Lasmiditan— an innovative new drug in the ditan class

Unlike triptans, lasmiditan penetrates the central nervous system (CNS) and selectively targets 5‑HT1F receptors expressed in the trigeminal nerve pathway to offer effective treatment for migraine through non-vasoconstrictive activity.

Learn More

Lasmiditan Development Plan

 

devplan

 

VIEW THE FULL DEVELOPMENT PLAN